SMARCA4/2 loss reduces BCL-xL expression and confers a druggable MCL1 dependency in cancer
| Title: | SMARCA4/2 loss reduces BCL-xL expression and confers a druggable MCL1 dependency in cancer |
|---|---|
| Authors: | Jiang, JialinAff1, Aff2; Zhu, XianbingAff1, Aff2; Fu, ZhengAff1, Aff2; Liao, MinyanAff1, Aff2; Arabzadeh, AzadehAff1, Aff2; Robert, FrancisAff1, Aff2; Monast, AnieAff1, Aff2; Pilon, VirginieAff1, Aff2; Pavlakis, KittyAff3; Park, MoragAff1, Aff2, Aff4; Foulkes, William D.Aff5, Aff6, Aff7; Huang, SidongAff1, Aff2, Aff5, IDs4169802601350z_cor1 |
| Source: | npj Precision Oncology. 10(1) |
| Database: | Springer Nature Journals |